Regeneron sees ‘a lot of reason for hope’ as human testing of its coronavirus drug begins

The antibody cocktail is being tested in four human populations. Two groups of people will receive the drug to test its effectiveness as a treatment for Covid-19; the other two will receive it as a possible prevention. CNBC